Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
204.73
+2.39 (1.18%)
Apr 28, 2026, 11:33 AM EDT - Market open
Cardinal Health Stock Forecast
Stock Price Forecast
The 11 analysts that cover Cardinal Health stock have a consensus rating of "Buy" and an average price target of $232.27, which forecasts a 13.45% increase in the stock price over the next year. The lowest target is $186 and the highest is $258.
Price Target: $232.27 (+13.45%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Cardinal Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 3 | 3 | 3 |
| Buy | 6 | 7 | 7 | 7 | 7 | 8 |
| Hold | 2 | 2 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 12 | 11 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 28, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $260 → $240 | Buy | Maintains | $260 → $240 | +17.23% | Apr 8, 2026 |
| Barclays | Barclays | Buy Maintains $243 → $258 | Buy | Maintains | $243 → $258 | +26.02% | Feb 24, 2026 |
| JP Morgan | JP Morgan | Hold Maintains $209 → $243 | Hold | Maintains | $209 → $243 | +18.69% | Feb 10, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $237 → $256 | Buy | Maintains | $237 → $256 | +25.04% | Feb 10, 2026 |
Financial Forecast
Revenue This Year
261.23B
from 222.58B
Increased by 17.36%
Revenue Next Year
284.89B
from 261.23B
Increased by 9.06%
EPS This Year
10.41
from 6.45
Increased by 61.37%
EPS Next Year
11.69
from 10.41
Increased by 12.35%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 276.7B | 307.7B | |||
| Avg | 261.2B | 284.9B | |||
| Low | 250.8B | 267.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 24.3% | 17.8% | |||
| Avg | 17.4% | 9.1% | |||
| Low | 12.7% | 2.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 10.95 | 12.34 | |||
| Avg | 10.41 | 11.69 | |||
| Low | 10.00 | 11.03 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 69.8% | 18.5% | |||
| Avg | 61.4% | 12.3% | |||
| Low | 55.0% | 6.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.